Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Omeros (OMER) and Urogen Pharma (URGN)

TipRanksApr 9 19:40

Omeros Corporation's $50M Buyback Plan: A Double-Edged Sword for Stock Stability

TipRanksApr 3 14:01

Omeros Shares Down 6% on Swing to 4Q Loss

By Denny Jacob Omeros shares edged down 6% to $3 a reporting a swing to a loss in the fourth quarter. The stock is down 8.3% so far this year. The biopharmaceutical company posted a loss of $9.1 mi

WSJApr 2 23:07

Omeros (OMER) Gets a Hold From Needham

TipRanksApr 2 18:27

Earnings Call Summary | Omeros(OMER.US) Q4 2023 Earnings Conference

The following is a summary of the Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript:Financial Performance:Omeros reported a Q4 2023 net loss of $9.1 million, or $0.15 per share, compared to a

Futu NewsApr 2 09:28 · Conference Call

Omeros Corp. Q4 Earnings Summary

RTTNewsApr 2 04:40